Select Publications
Conference Papers
, 2025, 'KRAS Mutations in Australian Gastrointestinal Cancer Patients: An Analysis of the Molecular Screening and Therapeutics (MoST) Program', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY
, 2025, 'Real-World Trends, Rural-Urban Differences, and Socioeconomic Disparities in Access to and Utilisation of Tumour Genomic Profiling within a Tasmanian Population', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY
, 2024, 'Ipatasertib in patients with AKT1/2/3 mutation-positive (AKTmut) tumors: TAPISTRY study', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Special Clinical Science Symposia, ELECTR NETWORK, 29 May 2024 - 29 May 2024
, 2024, 'Multi-omic immunophenotyping to identify predictors of mRNA vaccine responsiveness in immunocompromised individuals', in The Journal of Immunology, Oxford University Press (OUP), pp. 1550_4167 - 1550_4167, http://dx.doi.org/10.4049/jimmunol.212.supp.1550.4167
, 2024, 'Prevalence and co-mutation status of MTAP deletions', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 116 - 116
, 2023, 'EXPLORING THE PROGNOSTIC IMPLICATIONS OF MOLECULAR ALTERATIONS IN ASTROCYTOMAS USING COMPREHENSIVE GENOMIC PROFILING (CGP)', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, CANADA, Vancouver, presented at 28th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO), CANADA, Vancouver, 15 November 2023 - 19 November 2023
, 2023, 'Clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2023 - 06 June 2023
, 2023, 'Long-term clinical and psychosocial outcomes of surveillance in Li Fraumeni syndrome.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2023 - 06 June 2023
, 2023, '88TiP A phase Ib study of HMBD-001, a monoclonal antibody targeting HER3, with or without chemotherapy in patients with genetic aberrations in HER3 signaling', in Annals of Oncology, Elsevier, pp. s1501, http://dx.doi.org/10.1016/j.annonc.2023.10.788
, 2023, 'Computer Vision Assisted Collision Avoidance for Radiation Therapy', in AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, LIPPINCOTT WILLIAMS & WILKINS, pp. S82 - S82
, 2022, 'A population-based, whole genome sequencing approach to mapping the genetic basis of mesenchymal malignancies', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH
, 2021, 'Delivering personalized care and research for rare cancers in the increasingly genomic world?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500102&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Effectively communicating comprehensive tumour genomic profiling results: Mitigating uncertainty for advanced cancer patients', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 180 - 180, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500295&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'MOST study', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 91 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500101&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Psychological outcomes in advanced cancer patients after receiving genomic tumour profiling results', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 198 - 198, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500332&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'MTOR signaling orchestrates stress-induced mutagenesis facilitating adaptive evolution in human cancers', in CANCER SCIENCE, WILEY, pp. 182 - 182, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000618060100103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Feasibility of using the Paediatric Measure Yourself Medical Outcome Profile (P-MYMOP) at a paediatric outpatient department', in QUALITY OF LIFE RESEARCH, SPRINGER, pp. S76 - S77
, 2021, 'GENETICALLY DETERMINED HEIGHT, BIRTHWEIGHT, AND PUBERTY TIMING AND RISK OF OSTEOSARCOMA', in PEDIATRIC BLOOD & CANCER, WILEY, pp. S66 - S66
, 2020, 'Outcomes in rare cancer patients who underwent comprehensive genomic sequencing in the NOMINATOR study', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 70 - 70, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000790145400028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'Abstract IA13: Molecular targeted therapies and precision medicine for children with neuroblastoma and other refractory malignancies', in Cancer Research, American Association for Cancer Research (AACR), pp. ia13 - ia13, http://dx.doi.org/10.1158/1538-7445.pedca19-ia13
, 2020, 'NOMINATOR: Feasibility of genomic testing of rare cancers to match cancer to treatment.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368300004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'How much do cancer patients value whole genome sequencing? A cross-sectional survey using the willingness-to-pay technique', in EUROPEAN JOURNAL OF HUMAN GENETICS, SPRINGERNATURE, pp. 790 - 790
, 2020, 'Psychological impact of comprehensive genomic profiling results to advanced cancer patients', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 92 - 92
, 2019, 'Who should access germline genome sequencing? A mixed methods study of patient views', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 92 - 93, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400100&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Abstract 2434: Characterizing age-of-onset of multiple primary cancers and specific cancer types in families with Li-Fraumeni syndrome', in Cancer Research, American Association for Cancer Research (AACR), pp. 2434 - 2434, http://dx.doi.org/10.1158/1538-7445.am2019-2434
, 2019, 'Abstract 2434: Characterizing age-of-onset of multiple primary cancers and specific cancer types in families with Li-Fraumeni syndrome', American Association for Cancer Research (AACR), pp. 2434 - 2434, presented at Prevention, Early Detection, and Interception, http://dx.doi.org/10.1158/1538-7445.sabcs18-2434
, 2019, 'Translating genomic risk into an early detection strategy for sarcoma', in Genes Chromosomes and Cancer, pp. 130 - 136, http://dx.doi.org/10.1002/gcc.22697
, 2019, 'Association of Sarcopenia with Health related Quality of Life in Cirrhotics', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 710 - 710
, 2019, 'Bismuth based Quadruple therapy (BQT) versus Concomitant therapy (CCT) for H.pylori eradication-A real world experience', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 468 - 468
, 2019, 'Changes in spleen stiffness (SS) measured by shear wave elastography (SWE) before and after endoscopic variceal ligation (EVL)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 573 - 573
, 2019, 'FAT Score, A novel predictive score to differentiate Non-alcoholic steatohepatitis (NASH) from Non alcoholic fatty liver disease without NASH', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 515 - 515
, 2019, 'HAM score,A novel predictor model of 3 month mortality in Decompensated Liver Disease (DCLD)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 742 - 742
, 2019, 'Irritable bowel syndrome in medical and nonmedical students by Rome IV criteria - time to revamp?', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 345 - 345
, 2018, 'Advanced cancer patient perspectives on consenting to molecular tumour profiling: A qualitative study', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 144 - 144, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200232&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'Young cancer patient perspectives on undertaking whole genome sequencing: A qualitative study', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 144 - 144, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200231&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'Abstract 2077: Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients', in Cancer Research, American Association for Cancer Research (AACR), pp. 2077 - 2077, http://dx.doi.org/10.1158/1538-7445.am2018-2077
, 2018, 'Abstract 4994: p53 and RB regulate Hedgehog responsiveness via autophagy-mediated ciliogenesis', in Cancer Research, American Association for Cancer Research (AACR), pp. 4994 - 4994, http://dx.doi.org/10.1158/1538-7445.am2018-4994
, 2018, 'Abstract LB-121: Exploring the germ-line contribution to exceptional response to PD-1/PD-L1 inhibition in patients with metastatic non-small-cell lung cancer by whole genome sequencing', in Cancer Research, American Association for Cancer Research (AACR), pp. lb-121-lb-121, http://dx.doi.org/10.1158/1538-7445.am2018-lb-121
, 2018, 'Young cancerpatient perspectives on undertaking whole genome sequencing: A qualitativestudy', in EUROPEAN JOURNAL OF HUMAN GENETICS, SPRINGERNATURE, ITALY, Milan, pp. 722 - 723, presented at 51st Conference of the European-Society-of-Human-Genetics (ESHG) in conjunction with the European Meeting on Psychosocial Aspects of Genetics (EMPAG), ITALY, Milan, 16 June 2018 - 19 June 2018
, 2018, 'Abstract B32: Lymphocytes and immune checkpoint biomarker expression in sarcomas', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. B32 - B32, http://dx.doi.org/10.1158/1557-3265.sarcomas17-b32
, 2018, 'Abstract IA03: Translating genomic risk into an early detection strategy for sarcoma', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. IA03 - IA03, http://dx.doi.org/10.1158/1557-3265.sarcomas17-ia03
, 2018, 'Abstract PR13: Pivotal role of interleukin 23 in osteosarcoma development and its link with glutamate metabotropic 4: Identification of novel therapeutic targets for osteosarcoma', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. pr13 - pr13, http://dx.doi.org/10.1158/1557-3265.sarcomas17-pr13
, 2017, 'PD-1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), pp. 3060 - 3060, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.3060
, 2017, 'Lymphocytes and immune checkpoint biomarker expression in sarcomas.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, pp. 70 - 71, presented at AACR Special Conference on Advances in Sarcomas - From Basic Science to Clinical Translation, PA, Philadelphia, 16 May 2017 - 19 May 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000422882000095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Pivotal role of interleukin 23 in osteosarcoma development and its link with glutamate metabotropic 4: Identification of novel therapeutic targets for osteosarcoma.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, pp. 33 - 34, presented at AACR Special Conference on Advances in Sarcomas - From Basic Science to Clinical Translation, PA, Philadelphia, 16 May 2017 - 19 May 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000422882000036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Longitudinal variation of osteon circularity in three-dimensional reconstructions of Haversian networks', in AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY, WILEY, LA, New Orleans, pp. 273 - 273, presented at 86th Annual Meeting of the American-Association-of-Physical-Anthropologists (AAPA), LA, New Orleans, 19 April 2017 - 22 April 2017
, 2015, 'Imatinib mesylate (IM) activity in patients (pts) with locally advanced tenosynovial giant cell tumor/pigmented villonodular synovitis (TGCT).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358036900201&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'Machine-learning prediction of cancer survival: A prospective study examining the impact of combining clinical and genomic data.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), pp. 6521 - 6521, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.6521
, 2014, 'AN INTERNATIONAL SURVEY OF AWARENESS OF GENETIC RISK IN THE CLINICAL SARCOMA COMMUNITY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 22 - 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Response to treatment with denosumab in patients with giant cell tumor of bone (GCTB): FDG PET results from two phase 2 trials.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), pp. 10505 - 10505, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.10505